Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
The American Journal of Case Reports
|
June 29, 2023
Endometrial Adenocarcinoma with Discordant Microsatellite Stability Status Treated with First-Line Pembrolizumab: A Case Report and Narrative Review
Christopher R Grant, Elaine J Chiao, Zhaohui L Arter, et al.
Journal of Gastrointestinal Oncology
|
July 15, 2022
Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case report
Jacqueline Hsieh-Wong, James Liu, Jasmine Huynh, et al.
Investigational New Drugs
|
December 1, 2023
Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma
Jasmine C Huynh, May Cho, Arta Monjazeb, et al.
AME Case Reports
|
July 27, 2021
Complete response to neoadjuvant pembrolizumab and capecitabine in microsatellite stable, Epstein-Barr virus-positive, locally advanced gastric adenocarcinoma: case report
Ching Ying Lin, Pareen Mehta, Kevin M Waters, et al.
Genes
|
May 27, 2023
POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval
Mihir Bikhchandani, Farin Amersi, Andrew Hendifar, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 25, 2015
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma
May Cho, Andrea Wang-Gillam, Robert Myerson, et al.
Oncotarget
|
November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy
May Cho, Jun Gong, Paul Frankel, et al.
Molecular Cancer Therapeutics
|
February 8, 2020
Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy
Maike Zimmermann, Tao Li, Thomas J Semrad, et al.
Frontiers in Oncology
|
May 7, 2020
The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report
Sean J Judge, Jingran Ji, James Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 8, 2020
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series
Rahel Demisse, Neha Damle, Edward Kim, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
The American Journal of Case Reports
|
June 29, 2023
Endometrial Adenocarcinoma with Discordant Microsatellite Stability Status Treated with First-Line Pembrolizumab: A Case Report and Narrative Review
Christopher R Grant, Elaine J Chiao, Zhaohui L Arter, et al.
Journal of Gastrointestinal Oncology
|
July 15, 2022
Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case report
Jacqueline Hsieh-Wong, James Liu, Jasmine Huynh, et al.
Investigational New Drugs
|
December 1, 2023
Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma
Jasmine C Huynh, May Cho, Arta Monjazeb, et al.
AME Case Reports
|
July 27, 2021
Complete response to neoadjuvant pembrolizumab and capecitabine in microsatellite stable, Epstein-Barr virus-positive, locally advanced gastric adenocarcinoma: case report
Ching Ying Lin, Pareen Mehta, Kevin M Waters, et al.
Genes
|
May 27, 2023
POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval
Mihir Bikhchandani, Farin Amersi, Andrew Hendifar, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 25, 2015
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma
May Cho, Andrea Wang-Gillam, Robert Myerson, et al.
Oncotarget
|
November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy
May Cho, Jun Gong, Paul Frankel, et al.
Molecular Cancer Therapeutics
|
February 8, 2020
Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy
Maike Zimmermann, Tao Li, Thomas J Semrad, et al.
Frontiers in Oncology
|
May 7, 2020
The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report
Sean J Judge, Jingran Ji, James Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 8, 2020
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series
Rahel Demisse, Neha Damle, Edward Kim, et al.
Page
of 6